Share Article

Urenco Chairman Knighted in 2014 Queen’s Birthday Honours

16 June 2014 Global News

The Urenco Board is delighted to announce that Chairman, Dr John Hood, has received a Knighthood in the 2014 Queen's Birthday Honours list. 

Dr Hood has been made a Knights Companion with the title Sir John Hood KNZM for his services to tertiary education. 

Helmut Engelbrecht, CEO, Urenco, comments:

“John has made an outstanding contribution to education both in New Zealand and in the UK. On behalf of the Urenco Group, I congratulate him on the honour bestowed.”

Share Article

Line

More global stories

Urenco at COP30, Brazil

Global 19 November 2025

The importance of enabling a tripling of global nuclear capacity by 2050 from an industry and policy perspective was emphasised at the 30th UN Climate Change Conference (COP30) in Belém, Brazil.

Read more

The importance of enabling a tripling of global nuclear capacity by 2050 from an industry and policy perspective was emphasised at the 30th UN Climate Change Conference (COP30) in Belém, Brazil.

Read more

Urenco publishes small modular reactor report during COP30.

Read more

About Urenco

Urenco is an international supplier of uranium enrichment services, fuel cycle products and related solutions with sustainability at the core of our business. Operating in a pivotal area of the nuclear fuel supply chain for over 50 years, Urenco understands the importance of energy security and facilitates the reliable delivery of low carbon electricity generation for consumers around the world.

With its head office in London, UK, Urenco’s global presence ensures diversity and security of supply for customers through enrichment facilities in Germany, the Netherlands, the UK and the USA. Through our technology and the expertise of our people, the Urenco Group provides safe, cost effective and reliable services, operating within a framework of high environmental, social and governance standards, complementing international safeguards.

Urenco is making a positive contribution to global climate change goals through our core business and we are committed to achieving net zero carbon emissions by 2040.

We are committed to continued investment in the responsible management of nuclear materials; innovation activities with clear sustainability benefits, such as nuclear medicine, industrial efficiency and research; and nurturing the next generation of scientists and engineers.